TABLE 1.
No. | Herbs | Extract/Compound | Coronavirus type | CC50 (conc.) or cell survivability (%) | IC50 | SI | References |
---|---|---|---|---|---|---|---|
1. | Acanthopanax gracilistylus W.W.Sm. | Methanol extract | MHV-A59 | 170.0 ± 6.4 μg/ml | 0.9 ± 0.1 μg/ml | 188.9 | Kim et al. (2010) |
2. | Artemisia annua L. | Ethanol extract | SARS-CoV BJ-001 | 1,053.0 ± 92.8 μg/ml | 34.5 ± 2.6 μg/ml | 31 | Li et al. (2005) |
SARS-CoV BJ-006 | 1,053.0 ± 92.8 μg/ml | 39.2 ± 4.1 μg/ml | 27 | ||||
3. | Cimicifuga racemose (L.) Nutt. | Methanol extract | MHV-A59 | 239.0 ± 44.4 μg/ml | 19.4 ± 7.0 μg/ml | 12.3 | Kim et al. (2008) |
4. | Cinnamomum verum J.Presl (cortex) | Butanol extract | wtSARS-CoV | 180.0 ± 6.0 μg/ml | 7.8 ± 0.3 μg/ml | 23.1 | Zhuang et al. (2009) |
HIV/SARS-CoV | 444.0 ± 13.7 μg/ml | 85.3 ± 7.5 μg/ml | 5.2 | ||||
Procyanidin A2 | wtSARS-CoV | 1,116.7 ± 60.3 µM | 29.9 ± 3.3 µM | 37.35 | |||
HIV/SARS-CoV | 796.6 ± 63.7 µM | 120.7 ± 13.1 µM | 4.08 | ||||
Procyanidin B1 | wtSARS-CoV | 648.2 ± 43.4 µM | 41.3 ± 3.4 µM | 15.69 | |||
HIV/SARS-CoV | 656.2 ± 36.7 µM | 161.1 ± 20.3 µM | 4.08 | ||||
Cinnamtannin B1 | wtSARS-CoV | 184.7 ± 15.5 µM | 32.9 ± 3.9 µM | 5.61 | |||
HIV/SARS-CoV | 242.3 ± 14.8 µM | 32.9 ± 2.8 µM | 7.36 | ||||
5. | Coptis chinensis Franch. | Methanol extract | MHV-A59 | 71.3 ± 7.2 μg/ml | 2.0 ± 0.5 μg/ml | 34.9 | Kim et al. (2008) |
6. | Epimedium koreanum Nakai | Water extract | PEDV, SM98, TGE | ND | >90% at 1.5 mg/ml | ND | Cho et al. (2012) |
7. | Euphorbia neriifolia L. | 3β-friedelanol | HCoV | NC | 132.4% at 5 μg/ml | NC | Chang et al. (2012) |
3β-acetoxy friedelane | HCoV | NC | 80.9% at 5 μg/ml | NC | |||
Friedelin | HCoV | NC | 109.0% at 5 μg/ml | NC | |||
Epitaraxerol | HCoV | NC | 111.0% at 5 μg/ml | NC | |||
8. | Forsythia suspensa (Thunb.) Vahl | Forsythoside A | IBV | <1.28 mM | 0.64 mM | ND | Li et al. (2011) |
9. | Glycyrrhiza glabra L. | Glycyrrhizin | SARS-CoV | >20,000 mg/ml | 300 mg/ml | >67 | Cinatl et al. (2003), Hoever et al. (2005), Hoever et al. (2005) |
Glycyrrhizin | SARS-CoV | >24,000 μM | 365 ± 12 μM | >65 | |||
Glycyrrhetinic acid | SARS-CoV | >20 μM | 20 ± 5 μM | NC | |||
Derivative GL 1 | SARS-CoV | >3,000 μM | 40 ± 13 μM | >75 | |||
Derivative GL 2 | SARS-CoV | 1,462 ± 50 μM | 35 ± 7 μM | 41 | |||
Derivative GL 3 | SARS-CoV | 215 ± 18 μM | 139 ± 20 μM | 2 | |||
Derivative GL 9 | SARS-CoV | 44 ± 6 μM | 8 ± 2 μM | 6 | |||
Derivative GL 10 | SARS-CoV | 250 ± 19 μM | 50 ± 10 μM | 5 | |||
Derivative GL 11 | SARS-CoV | 15 ± 3 μM | 5 ± 3 μM | 3 | |||
Derivative GL 12 | SARS-CoV | 66 ± 8 μM | 16 ± 1 μM | 4 | |||
10. | Houttuynia cordata Thunb. | Water extract | IBV | 250 mg/ml | 62.5 mg/ml | 4 | Yin et al. (2011) |
Water extract | SARS-CoV | NC | 1,000 μg/ml | NC | Lau et al. (2008) | ||
Water extract | SARS-CoV | NC | 50, 100, 200, 400 and 800 μg/ml | NC | Lau et al. (2008) | ||
Ethyl acetate | MHV | >3.91 μg/ml | 0.98 μg/ml | >4.00 | Chiow et al. (2016) | ||
Quercetin | MHV | 116.52 μg/ml | 125 μg/ml | 0.93 | Chiow et al. (2016) | ||
11. | Isatis indigotica Fortune ex Lindl. | Water extract | SARS-CoV | >5,000 μg/ml | 191.6 ± 8.2 μg/ml | >26 | Lin et al. (2005) |
Indigo | SARS-CoV | 7,375 μM | 752 μM | 9.8 | |||
Sinigrin | SARS-CoV | >10,000 μM | 217 μM | >46 | |||
Beta-sitosterol | SARS-CoV | 1,475 μM | 1,210 μM | 1.21 | |||
Aloe emodin | SARS-CoV | 11,592 μM | 366 μM | 31.67 | |||
Hesperetin | SARS-CoV | 2,718 μM | 8.3 μM | 327.47 | |||
12. | Lindera aggregata (Sims) Kosterm. | Ethanol extract | SARS-CoV BJ-001 | 1,374.0 ± 39.0 μg/ml | 88.2 ± 7.7 μg/ml | 16 | Li et al. (2005) |
SARS-CoV BJ-006 | 1,374.0 ± 39.0 μg/ml | 80.6 ± 5.2 μg/ml | 17 | ||||
13. | Lycoris radiata (L'Hér.) Herb. | Ethanol extract | SARS-CoV BJ-001 | 886.6 ± 35.0 μg/ml | 2.4 ± 0.2 μg/ml | 370 | Li et al. (2005) |
SARS-CoV BJ-006 | 886.6 ± 35.0 μg/ml | 2.1 ± 0.2 μg/ml | 422 | ||||
Lycorine | SARS-CoV | 14,980 nM | 15.7 nM | 954.14 | |||
14. | Phoradendron meliae Trel. | Methanol extract | MHV-A59 | 334.3 ± 7.0 μg/ml | 13.0 ± 1.4 μg/ml | 25.6 | Kim et al. (2008) |
15. | Pelargonium sidoides DC. | Aqueous extract (EPs® 7630) | HCoV-229E | >100 μg/ml (87%) | 44.5 μg/ml | >2.3 | Michaelis et al. (2011) |
16. | Phellodendron chinense C.K.Schneid. | Methanol extract | MHV-A59 | 139.5 ± 81.3 μg/ml | 10.4 ± 2.2 μg/ml | 13.4 | Kim et al. (2008) |
17. | Polygonum multiflorum Thunb. (vine) | Water extract | SARS-CoV | NC | 1–10 μg/ml | NC | Ho et al. (2007) |
Polygonum multiflorum Thunb. (root) | Emodin | SARS-CoV | NC | 200 μM | NC | Ho et al. (2007) | |
Water extract | SARS-CoV | NC | 1–10 μg/ml | NC | Ho et al. (2007) | ||
18. | Pyrrosia lingua (Thunb.) Farw. | Chloroform | SARS-CoV BJ-001 | 2,378.0 ± 87.3 μg/ml | 43.2 ± 14.1 μg/ml | 55 | Li et al. (2005) |
SARS-CoV BJ-006 | 2,378.0 ± 87.3 μg/ml | 40.5 ± 3.7 μg/ml | 59 | ||||
19. | Rheum officinale Baill. (root) | Water extract/Emodin | SARS-CoV | NC | 1–10 μg/ml | NC | Ho et al. (2007) |
20. | Rheum palmatum L. | Ethyl acetate extract | SARS-CoV | NC | 13.76 ± 0.03 μg/ml | NC | Luo et al. (2009) |
21. | Rhus chinensis Mill. | Tetra-O-galloyl-β-d-glucose (TGG) | SARS-CoV | 1,080 μM | 4.5 μM | 240 | Wu et al. (2004) |
22. | Sanguisorba officinalis L. | Methanol extract | MHV-A59 | 388.4 ± 4.5 μg/ml | 3.7 ± 1.4 μg/ml | 105.0 | Kim et al. (2010) |
23. | Sambucus formosana Nakai | Ethanol extract | HCoV-NL63 | 180.62 ± 63.04 μg/ml | 1.17 ± 0.75 μg/ml | 154.37 | Weng et al. (2019) |
Caffeic acid | HCoV-NL63 | >500 μM | 3.54 ± 0.77 μM | NC | |||
Chlorogenic acid | HCoV-NL63 | >500 μM | 43.45 ± 6.01 μM | NC | |||
Gallic acid | HCoV-NL63 | >500 μM | 71.48 ± 18.40 μM | NC | |||
24. | Sophora flavescens Aiton | Methanol extract | MHV-A59 | 556.8 ± 2.9 μg/ml | 0.8 ± 0.2 μg/ml | 696.0 | Kim et al. (2010) |
25. | Sophora subprostrata Chun & T.Chen | Methanol extract | MHV-A59 | 307.3 ± 6.6 μg/ml | 27.5 ± 1.1 μg/ml | 11.1 | Kim et al. (2008) |
26. | Stephania tetrandra S.Moore | Tetrandrine | HCoV-OC43 | 13.41 ± 0.36 μM | 0.33 ± 0.03 μM | 40.19 | Kim et al. (2019) |
Fangchinoline | HCoV-OC43 | 11.54 ± 0.46 μM | 1.01 ± 0.07 μM | 11.46 | |||
Cepharanthine | HCoV-OC43 | 11.26 ± 0.69 μM | 0.83 ± 0.07 μM | 11.63 | |||
27. | Strobilanthes cusia (Nees) Kuntze | Methanol extract | HCoV-NL63 | >100 μg/ml | 0.64 ± 0.43 μg/ml | 156.25 | Tsai et al. (2020) |
Tryptanthrin | HCoV-NL63 | >400 μM | 1.52 ± 0.13 μM | 263.16 | |||
Indigodole B | HCoV-NL63 | >400 μM | 2.60 ± 0.11 μM | 153.85 | |||
28. | Toona sinensis (Juss.) M.Roem. | Water extract | SARS-CoV | >500 μg/ml | 30–43 μg/ml | 17 | Chen et al. (2008) |
29. | Torilis japonica (Houtt.) DC. | Methanol extract | MHV-A59 | 156.5 ± 2.6 μg/ml | 0.8 ± 0.0 μg/ml | 195.6 | Kim et al. (2010) |
30. | Veronica linariifolia Pall. ex Link | Luteolin | SARS-CoV | 10,600 μM | 10.6 μM | 14.62 | Wu et al. (2004) |
31. | Various (Chinese medicinal herbs) | Emodin | SARS-CoV | NC | 50% at 20 μM | NC | Schwarz et al. (2012) |
Kaempferol | SARS-CoV | NC | 20% at 20 μM | NC | |||
Kaempferol glycosides | SARS-CoV | NC | >50% at 20 μM | NC | |||
32. | Various (used flavonoid library) | Herbacetin | MERS & SARS-CoV | NC | 33.17–40.59 μM | NC | Jo et al. (2019), Jo et al. (2020) |
Rhoifolin | SARS-CoV | NC | 27.45 μM | NC | Jo et al. (2020) | ||
Pectolinarin | SARS-CoV | NC | 37.78 μM | NC | Jo et al. (2020) | ||
Isobavachalcone | MERS-CoV | NC | 35.85 μM | NC | Jo et al. (2019) | ||
Quercetin 3-β-d glucoside | MERS-CoV | NC | 37.03 μM | NC | Jo et al. (2019) | ||
Helichrysetin | MERS-CoV | NC | 67.04 μM | NC | Jo et al. (2019) |
CC50 is the cytotoxicity concentration of the extracts or compounds that can inhibit 50% population of host cells. IC50 is the inhibitory concentration of the extracts or compound that can cause 50% of virus inhibition or reduction after it has been treated with extract/compound. Selectivity index (SI) is calculated based on the ratio of CC50/IC50. The higher the value of SI, the lesser cytotoxicity for the host and hence being potentially safe to be applied as a future antiviral agent. NC is non-calculable, and ND is data not determined/shown from respective articles.
Abbreviation: MHV, mouse hepatitis virus; wtSARS-CoV; wild-type SARS coronavirus; HIV, human immunodeficiency virus; PEDV, porcine epidemic diarrhea virus; TGE, transmissible gastroenteritis coronavirus; HCoV, human coronavirus; IBV, avian coronavirus; 3CLpro, 3-chymotrypsin-like cysteine protease; PLpro, papain-like protease 2; RdRp, RNA-dependent RNA polymerase; SARS, severe acute respiratory syndrome; MERS, middle east respiratory syndrome